Related Experiment Video
Updated: Jul 10, 2026
10:39
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
Translational research on vaccines: influenza as an example
1Division of Infectious Diseases and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Missouri, USA. belsherb@slu.edu
Clinical Pharmacology and Therapeutics
|November 1, 2007
Summary
Advancements in influenza vaccine research are creating new products through translational science. This robust pipeline includes novel vaccine types and production methods, promising improved public health outcomes.
Area of Science:
- Immunology
- Vaccinology
- Translational Research
Background:
- Influenza vaccine development exemplifies translational research, bridging biological discoveries with practical applications.
- Current research explores diverse vaccine platforms and production methods, moving beyond traditional egg-based systems.
Purpose of the Study:
- To review the landscape of novel influenza vaccine development.
- To discuss the role of translational research in creating new vaccines.
- To examine the limitations and future prospects of influenza vaccine innovation.
Main Methods:
- Review of modern vaccine technologies including recombinant proteins, polynucleotide vaccines, conjugate vaccines, peptides, expression vectors, and live attenuated vaccines.
- Exploration of novel adjuvants to enhance vaccine efficacy and reduce antigen dosage.
- Discussion of reverse genetics applications in vaccine design.
- Analysis of translational research challenges, including predicting clinical outcomes and the role of post-licensure (Phase IV) studies.
Main Results:
- A robust pipeline of new influenza vaccines is emerging, utilizing a wide array of modern biological research approaches.
- Innovations in vaccine production, such as tissue culture, offer alternatives to traditional egg-based methods.
- The study highlights the potential of new vaccine candidates and the importance of rigorous evaluation.
Conclusions:
- Translational research is crucial for advancing influenza vaccine development, with a promising pipeline of innovative products.
- Careful interpretation of data and post-marketing surveillance are essential for ensuring vaccine safety and effectiveness.
- Continued investment and research are expected to yield several new influenza vaccines for clinical use.
Related Concept Videos
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
02:33Initiation of Translation
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
00:57Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
01:51Vaccinations
Overview